Study Reveals Medications Associated With Lower Odds of Severe Infection
Tuesday, June 28, 2022
Many researchers studying COVID-19 have spent the past two years poring over test tubes and isolated cells. However, large troves of data about people’s interactions with the healthcare system can also be a rich source of useful insights. Using one such database, IRP researchers found that older adults taking certain medications were less likely to catch COVID or experience severe repercussions from the virus.
Study Identifies Compounds That Could Aid Body’s Removal of Toxic Cancer Drugs
Tuesday, May 17, 2022
When it comes to cancer, the treatment can sometimes feel worse than the disease. Not only do chemotherapy drugs cause grueling side effects, but certain products made by otherwise benign bacteria living in our digestive system can interfere with the body’s ability to get rid of those toxic chemicals. A new IRP study used a cutting-edge computational approach to help identify compounds that inhibit one of those meddling bacterial molecules, which could eventually lead to the creation of medications that reduce some of chemotherapy’s side effects.
Many NIH Labs Remain Focused on COVID Research
Monday, February 14, 2022
Since the early days of the COVID-19 pandemic, IRP researchers have been hard at work learning about the virus and developing ways to prevent and treat infections. That research remains as important as ever, particularly as the new Omicron variant of the virus continues to spread rapidly.
Fortunately, NIH’s Intramural Targeted Anti-COVID-19 Program (ITAC) has been providing IRP scientists with millions of dollars to support their research on the pandemic virus, known as SARS-CoV-2. Last week, the “I Am Intramural” blog discussed ITAC-funded efforts to learn about the biology of the virus and how it affects the body. This week, we’ll look at IRP projects focused on ways to track, treat, and prevent infections.
Research in Cells Shows Promise for an Alternative Way to Halt Sperm Production
Tuesday, February 1, 2022
Birth control has long been mostly one-sided, as the vast majority of contraceptive methods are intended exclusively for women. However, recent IRP research has shown the potential of a new approach towards creating a reversible method of male contraception.
Women have a vast array of contraceptive options available to them, from ‘the pill’ to intrauterine devices (IUDs) and other products. However, for men, the only options aside from condoms are safe but irreversible surgical procedures. More than 40 percent of pregnancies in the U.S. are unintended, and additional options for male birth control could help reduce that number.
Computational Biology Research Conducted at NIH Garners $25,000 Prize
Monday, April 8, 2019
The IRP is home to some of today’s and tomorrow’s greatest scientific minds. Hundreds of budding biomedical pioneers begin honing their scientific skills here in high school, but very few win distinction as quickly as seventeen-year-old Daniel Schäffer, whose IRP research earned him inclusion among this year’s 40 finalists in the prestigious Regeneron Science Talent Search.